AI assistant
Sending…
DEXCOM INC — Director's Dealing 2016
Sep 6, 2016
30198_dirs_2016-09-06_ddb54a78-b04c-4876-aff7-4d60a92951bf.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2016-09-01
Reporting Person: LORD JONATHAN T MD (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-09-01 | Common Stock | S | 10000.0 | $91.5 | Disposed | 52820 | Direct |
Footnotes
F1: Since the date of the reporting person's last Form 4, 63,553 shares of Dexcom Inc. Common stock were transferred to his former spouse pursuant to a domestic relations order. Included in this number are 4,791 unvested restricted stock units which were granted on May 25, 2016 and shall vest on May 25, 2017.
More from DEXCOM INC
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 14
Interim / Quarterly Report
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 15
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 2
Director's Dealing
2026
Feb 26
Regulatory Filings
2026
Feb 26
Director's Dealing
2026
Feb 17